These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6420993)

  • 21. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pregnant Rhesus negative Nigerian woman.
    Kotila TR; Odukogbe AA; Okunlola MA; Olayemi O; Obisesan KA
    Niger Postgrad Med J; 2005 Dec; 12(4):305-7. PubMed ID: 16380744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rhesus incompatibility and anti-D prevention in the Düsseldorf region (a ten-year survey) (author's transl)].
    Göbel U; Haering M; Fertmann J; Voss HV; Petrich C
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2010-3. PubMed ID: 808407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of specific immunoglobulin anti-D to prophylaxis of haemolytic disease of the newborn].
    Bianu V; Zervos G; Kondi V; Balan S
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):569-71. PubMed ID: 17474215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rhesus-prophylaxis during interventions in early pregnancy].
    Beck A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):613-8. PubMed ID: 6420996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
    Gligorović VN; Gligorović S; Susaković N; Lopicić L; Stolić I; Marković V; Matejić T
    Bilt Hematol Transfuz; 1976; 4(3):23-31. PubMed ID: 827283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [External quality control for anti-D demonstration within the scope of Rh immunoprevention].
    Lahmann N; Brandstädter W
    Zentralbl Gynakol; 1978; 100(4):208-10. PubMed ID: 418599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current problems of blood group incompatibility in pregnancy].
    Wilken H
    Zentralbl Gynakol; 1988; 110(1):1-11. PubMed ID: 3281396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn].
    Holtorff J; Brey J; Nitzsche M
    Zentralbl Gynakol; 1969 May; 91(20):629-47. PubMed ID: 4984542
    [No Abstract]   [Full Text] [Related]  

  • 34. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Post partum rubella vaccination and anti-D prevention].
    Pavelka R; Salzer H; Reinold E
    Zentralbl Gynakol; 1978; 100(16):1025-9. PubMed ID: 103339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of Rh immunization after delivery and abortion].
    Popović M; Zunić M; Stankić R; Aksentijević R; Vuksanović D; Pejović R
    Jugosl Ginekol Opstet; 1982; 22(5-6):131-3. PubMed ID: 6300570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two years' experience with Rh hemolytic disease reporting.
    Hawes WE; Mordaunt VL
    Calif Med; 1973 May; 118(5):28-32. PubMed ID: 4633598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
    Boulet S; Krause C; Tixier H; Bardou M; Sagot P
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.